SPRINGWORKS THERAPEUTICS INC's ticker is SWTX and the CUSIP is 85205L107. A total of 70 filers reported holding SPRINGWORKS THERAPEUTICS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,396,342 | -9.8% | 319,911 | +2.3% | 1.35% | +5.2% |
| Q2 2023 | $8,197,028 | +0.3% | 312,625 | -1.6% | 1.28% | -6.3% |
| Q1 2023 | $8,175,668 | -0.7% | 317,625 | +0.3% | 1.37% | -22.7% |
| Q4 2022 | $8,235,416 | -4.3% | 316,625 | +5.0% | 1.77% | +48.1% |
| Q3 2022 | $8,605,000 | -34.9% | 301,625 | -43.8% | 1.19% | -15.5% |
| Q2 2022 | $13,213,000 | -60.0% | 536,664 | -8.3% | 1.41% | -69.7% |
| Q1 2022 | $33,019,000 | +55.5% | 585,025 | +70.8% | 4.67% | +99.9% |
| Q4 2021 | $21,232,000 | +35.0% | 342,566 | +38.2% | 2.33% | +76.7% |
| Q3 2021 | $15,728,000 | -2.2% | 247,917 | +27.1% | 1.32% | +21.4% |
| Q2 2021 | $16,080,000 | +58.8% | 195,117 | +41.7% | 1.09% | +40.0% |
| Q1 2021 | $10,129,000 | +346.2% | 137,672 | +339.8% | 0.78% | +286.6% |
| Q4 2020 | $2,270,000 | -70.5% | 31,300 | -84.4% | 0.20% | -68.3% |
| Q4 2019 | $7,698,000 | +14.5% | 200,000 | -35.5% | 0.63% | -38.9% |
| Q3 2019 | $6,721,000 | – | 310,000 | – | 1.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bain Capital Life Sciences Investors, LLC | 5,831,307 | $480,558,000 | 31.49% |
| Consonance Capital Management LP | 1,199,339 | $98,838,000 | 11.90% |
| Boxer Capital, LLC | 2,075,905 | $171,075,000 | 6.04% |
| Perceptive Advisors | 9,699,824 | $799,362,000 | 5.19% |
| Orbimed Advisors | 6,044,266 | $498,108,000 | 5.04% |
| Samsara BioCapital, LLC | 169,852 | $13,998,000 | 1.73% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 1,375,775 | $113,378,000 | 1.50% |
| SPHERA FUNDS MANAGEMENT LTD. | 195,117 | $16,080,000 | 1.09% |
| Artal Group S.A. | 500,000 | $41,205,000 | 0.84% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 558,574 | $46,032,000 | 0.82% |